USDM Life Sciences

USDM Life Sciences is a specialized technology consulting firm serving pharmaceutical, biotech, medical device, and contract research organizations with over 20 years of life sciences industry experience. The company focuses on helping organizations navigate the complex regulatory requirements of GxP environments while implementing modern cloud-based enterprise systems.

USDM's core capabilities center on validation services, compliance consulting, and implementation of enterprise platforms from partners including Veeva, Salesforce, Microsoft, SAP, and Google Cloud. Their Cloud Assurance methodology provides pre-validated frameworks that reduce validation workload by up to 60% while maintaining 21 CFR Part 11 and EU Annex 11 compliance. The firm delivers solutions across quality management, regulatory content management, clinical trial operations, and intelligent workflow automation.

The company demonstrates measurable impact through documented client results, including 500 hours saved per clinical study through AI-driven query management and $200,000 in annual IT cost reductions through cloud migration. Their integration accelerators, such as the Veeva-DocuSign connector, address common operational bottlenecks in regulated document workflows.

Select USDM when your organization needs to implement or migrate enterprise systems within GxP-regulated environments and requires validation expertise that reduces compliance burden. Their Cloud Assurance approach provides pre-validated frameworks that accelerate deployment timelines while maintaining regulatory compliance.

Expect structured engagement models focused on platform implementation, validation documentation, and compliance consulting rather than custom development. The firm's integration accelerators and domain expertise deliver particular value when connecting multiple enterprise systems (Veeva, Salesforce, DocuSign) within validated workflows.

USDM exclusively serves the life sciences sector of healthcare, focusing on pharmaceutical manufacturers, biotechnology companies, medical device makers, CROs, and CMOs. Their expertise addresses the specific regulatory requirements of GxP environments including 21 CFR Part 11, EU Annex 11, and FDA/EMA audit readiness.

The firm's solutions target critical life sciences workflows including clinical trial operations, regulatory submissions, quality management, deviation and CAPA processes, and manufacturing quality control. Their compliance-first approach specifically addresses the validation, audit trail, and electronic signature requirements unique to drug and device development rather than broader healthcare IT needs.

Life sciences manufacturers and research organizations with $50M+ revenue implementing cloud-based enterprise systems, undergoing digital transformation from legacy infrastructure, or requiring ongoing managed validation services. Organizations operating in FDA-regulated or EMA-regulated markets that prioritize compliance expertise alongside technology implementation capabilities.